Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
Details for Australian Patent Application No. 2003300255 (hide)
International Classifications
Event Publications
27 May 2004 Complete Application Filed
Priority application(s): 60/434,952 19.12.02 US
19 August 2004 Application Open to Public Inspection
Published as AU-B-2003300255
5 June 2008 Assignment before Grant
Pharmacia Italia S.p.A. The application has been assigned to Pfizer Italia S.r.l. 2004
29 October 2009 Application Accepted
Published as AU-B-2003300255
25 February 2010 Standard Patent Sealed
24 February 2011 Assignment Registered
Pfizer Italia S.r.l. The patent has been assigned to Nerviano Medical Sciences S.r.l.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser